Safety Alerts & Recalls
Search all Safety Alerts & Recalls
Latest Alerts
Apotex Corp Recalls Single Lot of Oxybutynin Oral Solution
Apotex Corp has recalled a single lot of Oxybutynin Chloride Oral Solution, 5 mg/mL. Lot number HV7148 has been recalled because the solution may be different in color.
Oxybutynin chloride is used in the treatment of overactive bladder. Oxybutynin chloride is also sold under the brand name Ditropan, Ditropan XL, Gelnique, and Oxytrol. Oxybutynin is sold in other formulations such as tablets and patches. No other lots, strengths, formulations, or brands of oxybutynin chloride were involved in this recall.
To view the FDA notice about this recall, please visit
http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm229271.htm
Learn More
Fresenius Recalls Single Lot of PhosLo GelCaps
Fresenius Medical Care Holdings, Inc. and Braintree Laboratories Inc have recalled a single lot of PhosLo GelCap 667 mg. Lot number 1308035 has been recalled because this lot failed the manufacturer routine tests that measure the gelcaps' ability to dissolve.
PhosLo GelCaps contain the active ingredient calcium acetate and are commonly used in the treatment of high phosphate levels in the blood in end stage kidney disease. This recall alert only applies to the single lot of PhosLo (calcium acetate), 667 mg GelCaps. No other calcium acetate products were involved in this recall.
To view the FDA notice about this recall, please visit:
http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm229271.htm
Learn More